SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-102684
Filing Date
2022-09-23
Accepted
2022-09-23 16:18:57
Documents
5
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2226577-1_sc13da.htm SC 13D/A 41598
2 LETTER TO THE ISSUER: MEMBERS' REQUISITION OF A GENERAL MEETING tm2226577d1_ex-1.htm EX-1 28000
3 LETTER FROM THE REPORTING PERSONS TO THE SHAREHOLDERS OF THE ISSUER tm2226577d1_ex-2.htm EX-2 51769
4 GRAPHIC image_002.jpg GRAPHIC 4517
5 GRAPHIC image_001.jpg GRAPHIC 4949
  Complete submission text file 0001104659-22-102684.txt   136210
Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

IRS No.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91444 | Film No.: 221262562
SIC: 2834 Pharmaceutical Preparations